tiprankstipranks
International Flavors & Fragrances (IFF)
NYSE:IFF

International Flavors & Fragrances (IFF) AI Stock Analysis

821 Followers

Top Page

IFF

International Flavors & Fragrances

(NYSE:IFF)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
$72.00
â–¼(-2.40% Downside)
Action:ReiteratedDate:02/17/26
The score is driven primarily by uneven financial performance (recent loss despite resilient cash flow and lower debt). Earnings-call commentary is moderately constructive with modest 2026 growth and execution plans, while valuation is constrained by loss-making results. Technicals are supportive but appear overbought, adding near-term risk.
Positive Factors
Operating cash flow resilience
Consistent operating cash flow despite a net loss indicates durable cash-generation capacity. Positive OCF (~$0.85B in 2025) supports necessary CapEx, R&D and working-capital needs, cushions earnings volatility, and provides flexibility to fund deleveraging or share returns over the medium term.
Negative Factors
Profitability volatility and recent net loss
Swinging from modest profit to a 2025 net loss (-3.4% net margin) shows elevated earnings volatility. This reduces retained-earnings runway to self-fund growth, raises the bar on execution for margin recovery, and increases the risk that short-term shocks translate into longer-term cash-generation and investment constraints.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating cash flow resilience
Consistent operating cash flow despite a net loss indicates durable cash-generation capacity. Positive OCF (~$0.85B in 2025) supports necessary CapEx, R&D and working-capital needs, cushions earnings volatility, and provides flexibility to fund deleveraging or share returns over the medium term.
Read all positive factors

International Flavors & Fragrances (IFF) vs. SPDR S&P 500 ETF (SPY)

International Flavors & Fragrances Business Overview & Revenue Model

Company Description
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, an...
How the Company Makes Money
IFF makes money primarily by selling specialty ingredients and ingredient systems to business customers (B2B), typically large consumer packaged goods and food-and-beverage manufacturers. Its key revenue streams include: (1) Flavors: revenue from ...

International Flavors & Fragrances Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Highlights revenue contributions from different business segments, indicating which areas drive growth and profitability, and where strategic shifts might be needed.
Chart InsightsThe 2025 data reflect a structural reshaping more than pure demand swings: 'Nourish' vanishes as a new 'Taste' line appears and 'Pharma Solutions' collapses to zero, signaling reclassification or portfolio moves that distort year‑over‑year comparisons. Under the surface, Scent has genuine momentum (management flagged mid‑single‑digit growth and strong Fine Fragrance), Taste is contributing modest growth, and Health & Biosciences is weaker — aligning with the call’s cited headwinds. Combined margin improvement, leverage reduction and buyback activity suggest management is refocusing on higher‑margin fragrance/taste businesses.
Data provided by:The Fly

International Flavors & Fragrances Earnings Call Summary

Earnings Call Date:Feb 11, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 11, 2026
Earnings Call Sentiment Positive
The call highlights meaningful progress on balance sheet strengthening, disciplined capital allocation, margin expansion and targeted reinvestment in R&D and capacity—supported by solid segment-level wins in Taste, Scent (Fine Fragrance) and pockets of Health & Biosciences. These positives are tempered by continued top-line pressure and profitability volatility in Food Ingredients (notably Q4 weakness), commodity pressure in Fragrance Ingredients, a sizable free cash flow shortfall in 2025 driven by transaction-related charges and working capital builds, and modest near-term 2026 guidance with H1 comparability headwinds. Management has clear remediation plans (portfolio sales, productivity, innovation investments, cash-focused incentives) and expects improvements through 2026 and into 2027.
Positive Updates
Improved Leverage and Balance Sheet
Net debt to credit-adjusted EBITDA improved to 2.6x (from 3.8x in 2024); gross debt reduced to ~$6.0B (down nearly $3.0B vs 2024); cash & equivalents of $590M.
Negative Updates
Food Ingredients Revenue Weakness and Q4 Profitability Drop
Q4 Food Ingredients sales $802M, down ~4%; Q4 profitability declined ~11% to $82M driven by volume declines and unfavorable net pricing; full-year sales were down partly due to strategic exits of low-margin business and sanctions-related lost sales in Russia.
Read all updates
Q4-2025 Updates
Negative
Improved Leverage and Balance Sheet
Net debt to credit-adjusted EBITDA improved to 2.6x (from 3.8x in 2024); gross debt reduced to ~$6.0B (down nearly $3.0B vs 2024); cash & equivalents of $590M.
Read all positive updates
Company Guidance
The company guided 2026 sales of $10,500,000,000 to $10,800,000,000 (comparable currency‑neutral growth of 1%–4%) and EBITDA of $2,050,000,000 to $2,150,000,000 (comparable currency‑neutral EBITDA growth of 3%–8%), noting FX should be roughly +1 percentage point to sales and negligible to EBITDA; growth is expected to be volume‑driven (incremental margins on volume ~30%–35%), led by Taste, Health & Biosciences and Scent, with modest EBITDA growth expected in Q1 versus a like‑for‑like Q1 2025 base of about $55,000,000 (adjusting for divestitures) and progressive improvement thereafter. Management expects CapEx of ~6% of sales, productivity to fund selective reinvestment, higher Reg G/one‑time costs as the Food Ingredients sale process progresses, improved operating cash flow generation excluding those items, an operating cash‑flow‑conversion incentive metric (EBITDA − CapEx − change in net working capital), and intends to use potential sale proceeds to buy back shares and pay down debt while keeping net debt/credit‑adjusted EBITDA below a ~3.0x target (net debt/credit‑adjusted EBITDA was 2.6x at year‑end 2025).

International Flavors & Fragrances Financial Statement Overview

Summary
Mixed fundamentals: profitability has been volatile with a return to a net loss in 2025 and negative EBITDA margin, but operating cash flow remained positive and debt has trended down materially, supporting financial flexibility despite elevated earnings risk.
Income Statement
42
Neutral
Balance Sheet
58
Neutral
Cash Flow
63
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue10.89B11.48B11.48B12.44B11.66B
Gross Profit3.37B4.12B3.68B4.15B3.73B
EBITDA779.00M1.60B-996.00M-110.00M1.80B
Net Income-374.00M243.00M-2.56B-1.87B268.00M
Balance Sheet
Total Assets25.54B28.67B30.98B35.52B39.66B
Cash, Cash Equivalents and Short-Term Investments590.00M469.00M703.00M483.00M711.00M
Total Debt6.65B9.62B10.82B11.74B12.20B
Total Liabilities11.35B14.76B16.34B17.78B18.44B
Stockholders Equity14.15B13.88B14.61B17.66B21.08B
Cash Flow
Free Cash Flow256.00M602.00M936.00M-109.00M1.04B
Operating Cash Flow850.00M1.07B1.44B397.00M1.44B
Investing Cash Flow2.27B326.00M574.00M745.00M-18.00M
Financing Cash Flow-3.09B-1.61B-1.85B-1.23B-1.30B

International Flavors & Fragrances Technical Analysis

Technical Analysis Sentiment
Positive
Last Price73.77
Price Trends
50DMA
73.99
Negative
100DMA
70.50
Positive
200DMA
68.32
Positive
Market Momentum
MACD
-0.43
Negative
RSI
55.65
Neutral
STOCH
67.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IFF, the sentiment is Positive. The current price of 73.77 is above the 20-day moving average (MA) of 70.15, below the 50-day MA of 73.99, and above the 200-day MA of 68.32, indicating a neutral trend. The MACD of -0.43 indicates Negative momentum. The RSI at 55.65 is Neutral, neither overbought nor oversold. The STOCH value of 67.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IFF.

International Flavors & Fragrances Risk Analysis

International Flavors & Fragrances disclosed 23 risk factors in its most recent earnings report. International Flavors & Fragrances reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

International Flavors & Fragrances Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$13.92B21.0922.70%1.96%3.09%12.25%
68
Neutral
$8.47B15.458.09%5.33%-3.33%-19.59%
68
Neutral
$24.69B14.7133.60%2.71%-12.98%-11.34%
65
Neutral
$3.99B29.5011.63%1.70%4.25%56.51%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
57
Neutral
$18.84B-46.13-2.49%2.41%-3.01%82.30%
57
Neutral
$20.91B-32.60-5.13%1.10%-23.92%90.47%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IFF
International Flavors & Fragrances
73.77
4.08
5.86%
ALB
Albemarle
177.44
123.67
230.02%
EMN
Eastman Chemical
74.27
1.79
2.47%
PPG
PPG Industries
110.47
14.47
15.08%
RPM
RPM International
108.72
8.22
8.18%
SXT
Sensient Technologies
93.94
22.44
31.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 17, 2026